Additionally, this variant is commonly identified by CMA rather than by DMD‐specific testing, suggesting a dystrophinopathy is not initially specifically suspected at the time of testing. The gene discussed is DMD; the disease is neuromuscular disease caused by qualitative or quantitative defects of dystrophin.